Search - tctmd.com

Displaying 361 - 380 of 519

Sort: Relevancy | Date

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

News Daily News

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

June 21, 2013

Presentation

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Presenter: MW Cullen

June 20, 2013

News Daily News

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

Presentation TVT 2013

Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?

Presenter: Steven Goldberg

June 15, 2013

Presentation TVT 2013

LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense

Presenter: Matthew Price

June 15, 2013

Presentation TVT 2013

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Presenter: Ted Feldman

June 15, 2013

Presentation TVT 2013

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Presenter: Michael Ezekowitz

June 15, 2013

Presentation

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

Presenter: M. Lamberts

June 12, 2013

Presentation TCT Russia 2013

Emerging Anticoagulation Strategies for Elective PCI

Presenter: Roxana Mehran

June 09, 2013

Presentation

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Presenter: M. Urena

May 28, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Daily News

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Yael L. Maxwell

May 17, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

News Daily News

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Caitlin E. Cox

May 13, 2013

News Industry News

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

May 09, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

Advertisement

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?

LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

Emerging Anticoagulation Strategies for Elective PCI

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

Stroke After STEMI Unusual But Carries Poor Prognosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content